Omeprazole DR 10 MG capsule 30S
Ended Awarded
- Contract number
- SPE2DB25FTKQL
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,111
Award facts
- Contract value 100% obligated
- $2,111.04 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
On September 5, 2025, the Defense Logistics Agency (DLA) awarded a delivery order valued at $2,111.04 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The delivery order calls for the supply of Omeprazole DR 10 mg capsules in quantities of 30, with a firm fixed-price structure and an ultimate completion date of September 8, 2025. This award utilizes no specific set-aside designation, enabling the vendor to compete directly in the federal procurement marketplace. The contract represents performance at the vendor's Park Ridge location.
This delivery order is issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the DLA under the SPE2DB program, a $499.999 billion vehicle valid through November 2026 that enables the agency to procure a comprehensive range of pharmaceutical products supporting military healthcare facilities nationwide. DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, delivering branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables to Department of Defense healthcare sites. The vendor's contract portfolio demonstrates consistent performance across diverse pharmaceutical categories, positioning it as a primary source for routine pharmaceutical procurement within the DLA's medical supply operations.
Quick answers
Who was awarded contract SPE2DB25FTKQL?
SPE2DB25FTKQL was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 5, 2025.
How much is contract SPE2DB25FTKQL worth?
The government has obligated $2,111 on SPE2DB25FTKQL.
Is contract SPE2DB25FTKQL an order under another contract?
Yes. SPE2DB25FTKQL is a delivery order under SPE2DB22D9112, an indefinite delivery contract.
Was contract SPE2DB25FTKQL competed?
The extent of competition for SPE2DB25FTKQL was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award